Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions
Health and Quality of Life Outcomes · 2024
DOI: 10.1186/s12955-024-02287-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health and Quality of Life Outcomes, 2024. Verfasst von Lauren A Do und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 0…. Hauptthemen laut MEDLINE: Muscular Dystrophy, Duchenne, Quality of Life. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Duchenne muscular dystrophy (DMD) is a genetic disease resulting in progressive muscle weakness, loss of ambulation, and cardiorespiratory complications. Direct estimation of health-related quality of life for patients with DMD is challenging, highlighting the need for proxy measures. This study aims to catalog and compare existing published health state utility estimates for DMD and related conditions. METHODS: Using two search strategies, relevant utilities were extracted from the Tufts Cost-Effectiveness Analysis Registry, including health states, utility estimates, and study and patient characteristics. Analysis One identified health states with comparable utility estimates to a set of published US patient population utility estimates for DMD. A minimal clinically important difference of ± 0.03 was applied to each DMD utility estimate to establish a range, and the registry was searched to identify other health states with associated utilities that fell within each range. Analysis Two used pre-defined search terms to identify health states clinically similar to DMD. Mapping was based on the degree of clinical similarity. RESULTS: Analysis One identified 4,308 unique utilities across 2,322 cost-effectiveness publications. The health states captured a wide range of acute and chronic conditions; 34% of utility records were extrapolated for US populations (n = 1,451); 1% were related to pediatric populations (n = 61). Analysis Two identified 153 utilities with health states clinically similar to DMD. The median utility estimates varied among identified health states. Health states similar to the early non-ambulatory DMD phase exhibited the greatest difference between the median estimate of the sample (0.39) and the existing estimate from published literature (0.21). CONCLUSIONS: When available estimates are limited, using novel search strategies to identify utilities of clinically similar conditions could be an approach for overcoming the information gap. However, it requires careful evaluation of the utility instruments, tariffs, and raters (proxy or self).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 02111, USA. laurenatdo@gmail.com.
- Sarepta Therapeutics, Inc., Cambridge, MA, 02142, USA.
- Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, 02111, USA.
- Department of Medicine, The University of Chicago, Chicago, IL, 60637, USA.
Zitieren
APA
Do, L. A., Sedita, L. E., Klimchak, A. C., Salazar, R., & Kim, D. D. (2024). Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions. Health and Quality of Life Outcomes. https://doi.org/10.1186/s12955-024-02287-2
Vancouver
Do LA, Sedita LE, Klimchak AC, Salazar R, Kim DD. Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions. Health and Quality of Life Outcomes. 2024. doi:10.1186/s12955-024-02287-2
BibTeX
@article{Do2024,
author = {Do, Lauren A and Sedita, Lauren E and Klimchak, Alexa C and Salazar, Rachel and Kim, David D},
title = {Cataloging health state utility estimates for Duchenne muscular dystrophy and related conditions},
journal = {Health and Quality of Life Outcomes},
year = {2024},
doi = {10.1186/s12955-024-02287-2}
}
EUVIMED